Asthma Management in CHildren Based on Exhaled Nitric Oxide - Randomised Controlled Trial

• Conditions: Asthma; Respiratory - Asthma

• Registration Number: ACTRN12605000321640
• Lead Sponsor: Royal Children's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Children with asthma attending a paediatric specialist clinic.

Exclusion Criteria

Presence of other cardiorespiratory illness such as CF, trachemalacia, etc.Poorly compliant to treatment.Inability to take ICS or long acting beta-2-antagonists (LABA).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduced asthma exacerbations during 12 months[];Reduced asthma hospitalisations during 12 months[]

Secondary Outcome Measures

Name	Time	Method
Cough and asthma score[Completed daily for a duration of 12 months.];Child QOL and carer/parent QOL[Administered monthly for 4 months and then second monthly for 8 months. ]